Skip to main content
All lobbying filings

BROAD INSTITUTE INC.

Lobbying for BROAD INSTITUTE INC. · Biomedical and Genomic Research

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $70,000.00 expenses · posted Jul 20, 2026

Official filing document

 Bills named in this filing 4
  • HR 9260
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
  • HR 8800
    National Defense Authorization Act for Fiscal Year 2027
  • S 4784
    National Defense Authorization Act for Fiscal Year 2027
  • HR 9495
    Department of Defense Appropriations Act, 2027
 Lobbying activity 4
Budget/Appropriations

- General education about biomedical research and support for scientific funding. Transparency of federal funding for medical research dollars, including indirect costs. - Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. Support for the NIH All of Us Program. FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). - Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance. FY2027 National Defense Authorization Act (H.R.8800/S.4784) and FY2027 Department of Defense Appropriations Act (H.R.9495).

Science/Technology

- General education about biomedical research and support for scientific funding. - Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. - Federal policies and investments related to data infrastructure and artificial intelligence for biomedical research, including standards for secure and scalable data ecosystems.

Medical/Disease Research/Clinical Labs

- General education about biomedical research and support for scientific funding. - Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. - Education and awareness regarding genetic medicines for rare and ultra-rare diseases.

Defense

- Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance. FY2027 National Defense Authorization Act (H.R.8800/S.4784) and FY2027 Department of Defense Appropriations Act (H.R.9495). - Education and discussion regarding Broad Institute capabilities and technologies relevant to national biological intelligence, biosurveillance, and reconnaissance (ISR).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem